⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Green Bridge Announces Non-Brokered Private Placement for Gross Proceeds of up to C$4 Million
accessnewswire.com
DEFI
AMGN
House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English
prnewswire.com
ALKS
STG
GSK
SNY
TEVA
AZN
INCY
REGN
PFE
BMY
LLY
AMGN
ABBV
GILD
BIIB
CSL
VRTX
BHC
NVS
MRK
LEO
ALLT
CNTB
INM
Zack Kass to Headline ATD 2026
prnewswire.com
KO
MS
AMGN
Hazeltree 2025 Year-in-Review Finds Hedge Fund Crowding Diverged Sharply by Region
businesswire.com
GOOGL
MSFT
META
IBM
SNPS
BAC
USB
WFC
JPM
KEY
MRK
AMGN
TMO
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
globenewswire.com
JNJ
BIIB
NVS
VTRS
RPRX
ABBV
AZN
MRK
RIGL
GSK
REGN
GILD
AMGN
LLY
BMY
XBI
IBB
Biomedical and ICT Convergence Market Research Report 2025-2030: Outlook for Various Biomedical Products, Services, and Solutions Poised to Benefit from Various IT and Telecom Technologies - ResearchAndMarkets.com
businesswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MD
MRK
NVDA
NOVT
NVO
NXPI
PFE
SMCI
SOXX
TE
TXN
TMO
WMT
ZBH
Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease Control
prnewswire.com
AMGN
NVS
JNJ
PFE
GSK
ABBV
SNY
LLY
RO ANNOUNCES RESEARCH COLLABORATION TO BETTER UNDERSTAND AND IMPROVE THE REAL-WORLD PATIENT EXPERIENCE WITH GLP-1S
prnewswire.com
AMGN
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
prnewswire.com
BMRN
AMGN
BMY
MRK